135 related articles for article (PubMed ID: 8725560)
21. Invasive vs non-invasive treatment in acute coronary syndromes and prior bypass surgery.
Gurfinkel EP; Perez de la Hoz R; Brito VM; Duronto E; Dabbous OH; Gore JM; Anderson FA;
Int J Cardiol; 2007 Jun; 119(1):65-72. PubMed ID: 17045681
[TBL] [Abstract][Full Text] [Related]
22. Angina pectoris prior to myocardial infarction protects against subsequent left ventricular remodeling.
Solomon SD; Anavekar NS; Greaves S; Rouleau JL; Hennekens C; Pfeffer MA;
J Am Coll Cardiol; 2004 May; 43(9):1511-4. PubMed ID: 15120803
[TBL] [Abstract][Full Text] [Related]
23. Potential role of angiotensin-converting enzyme inhibition in myocardial ischemia and current clinical trials.
Pepine CJ
Clin Cardiol; 1997 Nov; 20(11 Suppl 2):II-58-64. PubMed ID: 9422854
[TBL] [Abstract][Full Text] [Related]
24. [Chrono-pharmacodynamics of capoten in patients with ischemic heart disease, postinfarction cardiosclerosis with cardiac failure].
Zaslavskaia RM; Zhamankulov KZh; Akhmetova AS; Teĭblium MM
Klin Med (Mosk); 2001; 79(12):33-5. PubMed ID: 11840808
[TBL] [Abstract][Full Text] [Related]
25. [ACE-inhibitors in angina pectoris].
Kjøller-Hansen L; Steffensen R; Grande P
Ugeskr Laeger; 1998 Mar; 160(10):1494-8. PubMed ID: 9520622
[No Abstract] [Full Text] [Related]
26. Relationship between serum angiotensin-converting enzyme activity and plasma plasminogen activator inhibitor activity in patients with recent myocardial infarction.
Moriyama Y; Ogawa H; Oshima S; Arai H; Takazoe K; Shimomura H; Hirai N; Suefuji H; Soejima H; Nishiyama K; Misumi K; Yasue H
Coron Artery Dis; 1998; 9(10):691-6. PubMed ID: 9894621
[TBL] [Abstract][Full Text] [Related]
27. Comparison of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the primary prevention of myocardial infarction in hypertensive patients.
Baer JT; Sauer WH; Berlin JA; Kimmel SE
Am J Cardiol; 2004 Aug; 94(4):479-81. PubMed ID: 15325933
[TBL] [Abstract][Full Text] [Related]
28. Effect of ACE inhibition on myocardial ischaemia.
Ferrari R
Eur Heart J; 1998 Sep; 19 Suppl J():J30-5. PubMed ID: 9796838
[TBL] [Abstract][Full Text] [Related]
29. Salvia miltiorrhiza and ischemic diseases.
Ji XY; Tan BK; Zhu YZ
Acta Pharmacol Sin; 2000 Dec; 21(12):1089-94. PubMed ID: 11603281
[TBL] [Abstract][Full Text] [Related]
30. Effects of zofenopril on myocardial ischemia in post-myocardial infarction patients with preserved left ventricular function: the Survival of Myocardial Infarction Long-term Evaluation (SMILE)-ISCHEMIA study.
Borghi C; Ambrosioni E;
Am Heart J; 2007 Mar; 153(3):445.e7-14. PubMed ID: 17307427
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of matrix metalloproteinase-9 activity by lisinopril after myocardial infarction in hamsters.
Takai S; Yamamoto D; Jin D; Inagaki S; Yoshikawa K; Tanaka K; Miyazaki M
Eur J Pharmacol; 2007 Jul; 568(1-3):231-3. PubMed ID: 17512521
[TBL] [Abstract][Full Text] [Related]
32. The effect of an angiotensin-converting enzyme inhibitor and a K+(ATP) channel opener on warm up angina.
Edwards RJ; Redwood SR; Lambiase PD; Marber MS
Eur Heart J; 2005 Mar; 26(6):598-606. PubMed ID: 15618027
[TBL] [Abstract][Full Text] [Related]
33. Angiotensin-converting enzyme inhibitors: ischemia is not the correct measure of benefit.
Anderson HV
J Am Coll Cardiol; 2003 Dec; 42(12):2060-2. PubMed ID: 14680726
[No Abstract] [Full Text] [Related]
34. Is a combination of verapamil and an ACE-inhibitor the optimal solution in ischaemic heart failure?
Jespersen CM
Cardiologia; 1995 Dec; 40(12 Suppl 1):307-10. PubMed ID: 8903054
[No Abstract] [Full Text] [Related]
35. [Angiotensin-converting enzyme inhibitors and chronic ischemic heart disease--new indications?].
Haghfelt T; Haghfelt A
Ugeskr Laeger; 2004 Jan; 166(3):169-70. PubMed ID: 14870648
[No Abstract] [Full Text] [Related]
36. AT1 receptor blockade for the prevention of cardiovascular events after myocardial infarction.
Azadpour M; Lamas GA
Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):891-902. PubMed ID: 15500434
[TBL] [Abstract][Full Text] [Related]
37. Effects of aspirin on angiotensin-converting enzyme inhibition and left ventricular dilation one year after acute myocardial infarction.
Davie AP
Am J Cardiol; 1999 Feb; 83(4):641. PubMed ID: 10073888
[No Abstract] [Full Text] [Related]
38. Endothelial function, fibrinolysis, and angiotensin-converting enzyme inhibition.
Vaughan DE
Clin Cardiol; 1997 Nov; 20(11 Suppl 2):II-34-7. PubMed ID: 9422850
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin-converting enzyme inhibitor trandolapril does not affect C-reactive protein levels in myocardial infarction patients.
de Maat MP; Kluft C; Gram J; Jespersen J
Circulation; 2003 Oct; 108(15):e113. PubMed ID: 14557351
[No Abstract] [Full Text] [Related]
40. Congestive heart failure and ischaemic heart disease treated with trandolapril and verapamil. DAVIT Study Group. Danish Verapamil Infarction Trial.
Hansen JF
J Hypertens Suppl; 1998 Jan; 16(1):S71-4. PubMed ID: 9534101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
